Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)
- 1 January 2016
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 43 (1) , 63-72
Abstract
No abstract availableKeywords
Funding Information
- Center for Translational Molecular Medicine, DeCoDe project (03O-101)
This publication has 28 references indexed in Scilit:
- MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A InhibitorsACS Medicinal Chemistry Letters, 2015
- Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosisBritish Journal of Cancer, 2013
- Cell Cycle Proteins Predict Recurrence in Stage II and III Colon CancerAnnals of Surgical Oncology, 2012
- TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progressionGut, 2011
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic AssaysClinical Cancer Research, 2011
- Shared and separate functions of polo-like kinases and aurora kinases in cancerNature Reviews Cancer, 2010
- Surgical Treatment of Hepatic Colorectal MetastasisThe Cancer Journal, 2010
- Colorectal cancerThe Lancet, 2010
- Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with 18F-FDG PET: A Randomized StudyJournal of Nuclear Medicine, 2009
- A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancerBritish Journal of Surgery, 2006